These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 12051269)
21. Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management. Halimi S Diabetes Metab; 2006 Dec; 32(6):555-6. PubMed ID: 17296508 [No Abstract] [Full Text] [Related]
22. Metformin discontinuation rate among patients with type-2 diabetes mellitus in Basrah, Iraq. Mansour AA; Habib OS Saudi Med J; 2007 Dec; 28(12):1919-21. PubMed ID: 18060234 [No Abstract] [Full Text] [Related]
23. Prevention of type 2 diabetes in the prediabetic population. Maji D; Roy RU; Das S J Indian Med Assoc; 2005 Nov; 103(11):609-11. PubMed ID: 16570766 [TBL] [Abstract][Full Text] [Related]
24. Current indications for metformin therapy. Tankova T Rom J Intern Med; 2003; 41(3):215-25. PubMed ID: 15526505 [TBL] [Abstract][Full Text] [Related]
26. A proof of concept, preliminary study to determine the effect of Yogasnas in controlling type 2 diabetes mellitus in newly detected subjects (when compared to metformin monotherapy). Viswanathan V; Chacko PT; Lavanya M; Tilak P J Assoc Physicians India; 2006 Dec; 54():965-6. PubMed ID: 17334022 [No Abstract] [Full Text] [Related]
27. [Diabetes mellitus--guidelines for general practice. Revised and expanded 2007 edition]. Wien Klin Wochenschr; 2007; 119(15-16 Suppl 2):5-64. PubMed ID: 17701075 [No Abstract] [Full Text] [Related]
28. Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride. Huo T; Cai S; Lu X; Sha Y; Yu M; Li F J Pharm Biomed Anal; 2009 May; 49(4):976-82. PubMed ID: 19249171 [TBL] [Abstract][Full Text] [Related]
30. Reducing the Risk of Developing Diabetes. ; Prebtani APH; Bajaj HS; Goldenberg R; Mullan Y Can J Diabetes; 2018 Apr; 42 Suppl 1():S20-S26. PubMed ID: 29650097 [No Abstract] [Full Text] [Related]
31. Reducing the risk of developing diabetes. ; Ransom T; Goldenberg R; Mikalachki A; Prebtani AP; Punthakee Z Can J Diabetes; 2013 Apr; 37 Suppl 1():S16-9. PubMed ID: 24070941 [No Abstract] [Full Text] [Related]
32. Prevention of diabetes: ethical consideration. Conradi PA BMJ; 2006 Oct; 333(7574):918. PubMed ID: 17068047 [No Abstract] [Full Text] [Related]
33. Can onset of diabetes be delayed? Nelson RL Postgrad Med; 2002 Sep; 112(3):121. PubMed ID: 12360651 [No Abstract] [Full Text] [Related]
34. The Diabetes Prevention Program and the metabolic syndrome. Sarinas PS; Dube DS Ann Intern Med; 2005 Oct; 143(7):544-5; author reply 545-6. PubMed ID: 16204171 [No Abstract] [Full Text] [Related]
35. Cost or revenue: is diabetes prevention doomed due to misalignment of incentives? Mainous AG; Yadav S; Xie Z; Huo J Fam Med Community Health; 2020; 8(1):e000274. PubMed ID: 32148736 [No Abstract] [Full Text] [Related]
36. Fulfilling our assignment to improve the health of all: good science just isn't enough. Ockene JK Ann Behav Med; 2006 Feb; 31(1):14-20. PubMed ID: 16472034 [No Abstract] [Full Text] [Related]
37. [Prediction and prevention of type 1 diabetes]. Jacquin P Arch Fr Pediatr; 1993 Nov; 50(9):826. PubMed ID: 8060215 [No Abstract] [Full Text] [Related]